Concepedia

Kathie M. Bishop

KM

32

Publications

8.8K

Citations

26

H-Index

2000

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Rush University Medical Center

Boston Children's Hospital

The University of Texas Southwestern Medical Center

Children's Hospital of Philadelphia

Kathie M. Bishop is an author at Ionis Pharmaceuticals (United States) specializing in medicine, neuroscience, and social sciences.

Top concepts

Publications per year

2000–2024

32

Publications

32

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Richard S. Finkel, Eugenio Mercuri, Basil T. Darras et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga et al. · New England Journal of Medicine · 2018 · 1.4K citations

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Richard S. Finkel, Claudia A. Chiriboga, Jiri Vajsar et al. · The Lancet · 2016 · 998 citations

, , +6

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 603 citations · Full text

Results from a phase 1 study of nusinersen (ISIS-SMN <sub>Rx</sub> ) in children with spinal muscular atrophy

Claudia A. Chiriboga, Kathryn J. Swoboda, Basil T. Darras et al. · Neurology · 2016 · 591 citations · Full text

Rows per page

1–5 of 32